COVID-19 vaccine information and updates
On Monday, Dec. 14, Oregon began receiving its first shipment of the new COVID-19 vaccine.
Oregon Health Authority officials have prioritized the most at-risk and hardest hit areas for vaccination. In Southern Oregon and across the state, health care workers and essential workers will get the vaccine first.
Asante will follow state and federal guidelines regarding the initial distribution of the limited supply, ensuring top-priority vaccination of our employees and providers who work in direct patient care locations.
Asante has begun Phase 1a vaccinations
The Pfizer-BioNTech vaccine is currently available to those working in a Phase 1A facility as defined by the OHA. This includes health care personnel and long-term care facility personnel and residents.
The vaccine is currently not available to the general public
Once the vaccine is widely available in 2021, Oregonians will likely have access to a vaccine through a doctor’s office, pharmacy or other location. Vaccination will be the safest, most effective and reliable way to keep yourself, your family and the community healthy and safe from the pandemic.
Until a vaccine is available to everyone, please continue taking actions to help prevent the spread of COVID-19:
Frequently Asked Questions
As part of our government’s response to COVID-19 several pharmaceutical companies are working on producing a vaccine. Per the Centers for Disease Control and Prevention (CDC), the intent of the vaccine is to support the human body in developing immunity to the virus.
Asante’s goal is to provide you with current information about a COVID-19 vaccination and its distribution when it becomes available.
Can I get COVID-19 from the vaccine?
No, the Pfizer-BioNTech COVID-19 does not contain live SARS-CoV-2 virus. Future vaccines in the pipeline such as the one developed by AstraZeneca do contain a live viral vector; others are likely to contain viral components and proteins as well.
Is the COVID-19 vaccine safe?
Safety is the number one priority of the CDC and FDA. Clinical trials are used to authorize or license vaccines for use.
The FDA authorized the Pfizer-BioNTech COVID-19 vaccine under an Emergency Use Authorization (EUA) based on two months of safety data. In most people, the vaccine causes only mild to moderate, short-lived side effects. Pfizer must collect six months of data to apply for full approval.
Getting vaccinated is the safest way to protect yourself from COVID-19.
How effective is the COVID-19 vaccine?
The Pfizer-BioNTech vaccine was found to be 95% effective at preventing infection with two doses in Phase 3 clinical trials.
When will the COVID-19 vaccine be available?
Pfizer, the first company to submit for Emergency Use Authorization (EUA), was approved Dec. 11. Southern Oregon will receive COVID-19 vaccine doses as early as Dec. 15.
Wider distribution of the COVID-19 vaccine will likely come in mid to late 2021 for the general public.
Who can get the COVID-19 vaccine?
The FDA has authorized emergency use of the Pfizer vaccine to prevent COVID-19 in people older than 16 year of age.
Asante will follow recommendations from the Oregon Health Authority and the CDC regarding initial distribution of the limited supply. Asante’s goal is a fair and equitable distribution of the vaccine. We will ensure the top priority for vaccination are staff and providers working in direct patient locations. Further prioritizations will be announced as vaccine supply is better understood.
The vaccine was not tested in pregnant women; at this point there is not data on safety and effectiveness in this population. Data are not available to assess the effects of the Pfizer-BioNTech COVID-19 vaccine on the breastfed infant.